NCT07465744

Brief Summary

The goal of this interventional study is to develop and evaluate a post-stroke patient support program aimed at enhancing patients' ability to self-management after discharge to home. The main question it aim to answer are: After participating in the support program, do patients show improvements in stroke-related knowledge, independence in activities of daily living, and self-efficacy in managing their health? Researchers will compare intervention to control group. The control group receive usual care. The intervention group receive usual care and support self management program to see enhance self-efficacy and recovery. Participants will:

  • Answer a self-report questionnaire
  • Attend to support self management program during 5 sessions in 5 weeks

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P75+ for not_applicable stroke

Timeline
4mo left

Started Apr 2026

Shorter than P25 for not_applicable stroke

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Apr 2026Oct 2026

First Submitted

Initial submission to the registry

March 6, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 12, 2026

Completed
20 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

March 12, 2026

Status Verified

March 1, 2026

Enrollment Period

6 months

First QC Date

March 6, 2026

Last Update Submit

March 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Self - Efficacy

    Using Stroke self-efficacy questionnaire (SSEQ). Total score ranging from 0 to 130, which is positive corelation to self-efficacy level.

    Five weeks after stroke

Secondary Outcomes (1)

  • Stroke self - management behaviors

    Five weeks after stroke

Other Outcomes (1)

  • Stroke Knowledge

    Five weeks after stroke

Study Arms (2)

Intervention

EXPERIMENTAL

The intervention group receive usual care and support self management program

Behavioral: Support self management programOther: Usual care

Control

OTHER

The control group receive usual care.

Other: Usual care

Interventions

Five sessions per five weeks of support self management program included stroke education and action planning; deliver rehabilitation, fall prevention, and problem-solving guidance; review progress and refine weekly action plans; reinforce adherence through follow-up; and summarize outcomes while establishing a continued self-management plan.

Intervention

Usual care

ControlIntervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older;
  • Clinically diagnosed with ischemic stroke or intracerebral hemorrhage (first-ever or recurrent episode);
  • Assessed by the treating physician as being clinically stable following the acute phase;
  • Mini-Mental State Examination (MMSE) score \> 18;
  • Scheduled for follow-up after discharge at the Neurology Outpatient Clinic or the Neurology Clinic, Department of Outpatient Services, University Medical Center Ho Chi Minh City;
  • Able to speak and read Vietnamese;
  • Willing to participate in educational sessions within the health self-management program;
  • Able to use a telephone;
  • Having a family member or caregiver accompanying the patient who is able to recognize changes in the patient's physical and mental condition;
  • Providing informed consent to participate in the study.

You may not qualify if:

  • Diagnosed with stroke secondary to cerebrovascular pathology related to malignancy;
  • Diagnosed with psychiatric disorders such as depression, schizophrenia, bipolar disorder, or personality disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2026

First Posted

March 12, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

March 12, 2026

Record last verified: 2026-03